BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. GATA1, nitric oxide metabolic process, Breast Cancer, Embryo, Laryngoscope, rs2476601)
Bookmark Forward

QuickView for STAT1;jsessionid=A9E7E7073C569C800C19BEE3DD9A17E6 (gene)


Body Atlas

Most Correlated Tissues

  1. T Lymphocyte (regulatory) of peripheral blood
  2. Natural killer cell of peripheral blood
  3. T Lymphocyte (CD4+) of peripheral blood
  4. Macrophage of peripheral blood
  5. Neutrophil of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Polymyositis
  2. Disease due to Trypanosomatidae
  3. Mycobacteriosis
  4. Disease caused by parasite
  5. Vaccination status
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Cyclizine
  2. 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one
  3. Polysaccharides
  4. Fluzone
  5. 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. HIP1
  2. FIGLA
  3. PCSK9
  4. NR2E3
  5. GREB1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. An inhibitory effect on the nuclear accumulation of phospho-STAT1 by its unphosphorylated form.
  2. STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Ma…
  3. Effects of SENP1-induced deSUMOylation of STAT1 on proliferation and invasion in nasopharyngeal carc…
  4. Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK …
  5. Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon s…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for STAT1;jsessionid=A9E7E7073C569C800C19BEE3DD9A17E6
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.